HHealthcare Read More Medicare Negotiates 71% Discount on Novo’s Ozempic, WegovyDecember 1, 2025 The US government said Tuesday it negotiated a 71% discount off of the list price of Novo Nordisk…
HHealthcare Read More Metsera calls Novo Nordisk’s new bid superior to Pfizer offerNovember 4, 2025 The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
HHealthcare Read More Pfizer files second lawsuit against Novo Nordisk, MetseraNovember 3, 2025 A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
HHealthcare Read More Pfizer sues Metsera, Novo Nordisk over rival obesity drug bidOctober 31, 2025 Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer said on Friday it had filed a lawsuit against Metsera and Novo…
HHealthcare Read More Pfizer’s Q3 2025 Earnings: What to ExpectOctober 19, 2025 With a market cap of $139.4 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company headquartered in New York, known…
MMarkets Read More What’s likely to move the market in the next trading sessionOctober 1, 2025 Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and…
MMarkets Read More What’s likely to move the market in the next trading sessionOctober 1, 2025 Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and…
HHealthcare Read More Pfizer’s new obesity bet, Metsera, releases drug dataSeptember 30, 2025 Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in…
HHealthcare Read More Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025September 27, 2025 More than 45 abstracts, including five late-breaking presentations and recognition in Presidential Symposium, showcase impact of approved medicines…
MMarkets Read More Wall Street rises to its first gain in 4 daysSeptember 26, 2025 NEW YORK (AP) — U.S. stocks climbed Friday and trimmed their losses for the week after a report…